EUVIMEDEUVIMED entdecken
Crossref

Effect of JM-20 on Age-Related Cognitive Impairment in Mice

Maylin Wong-Guerra, Yanay Montano-Peguero, Jeney Ramírez-Sánchez, Enrique García Alfonso, Daniela Hernández-Enseñat, Yeniceis Alcántara Isaac, Alejandro Saúl Padrón-Yaquis, João Batista Teixeira da Rocha, Luis Arturo Fonseca-Fonseca, Yanier Núñez-Figueredo

Neurochemical Research · 2025

DOI: 10.1007/s11064-024-04254-1 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Neurochemical Research, 2025. Verfasst von Maylin Wong-Guerra und 9 weiteren Autor:innen. Beteiligte Einrichtung: Laboratorio de Neurofarmacología Experimental, Centro de Investigación y Desarrollo de Medicamentos (CIDEM), Ave 26 No. 1605 Boyeros y Puentes Grande…. Hauptthemen laut MEDLINE: Cognitive Dysfunction, Aging. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 58 Literaturangaben. Gefördert von: This work was partially supported by the Innovation Financial Funding (FONCI-Cuba) project..

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The decline in cognitive function associated with aging significantly impacts the well-being of elderly individuals and their families. This decline is a major recognized risk factor for neurodegenerative diseases, notably Alzheimer's disease. Animal models of aging provide a platform for evaluating drugs concerning aspects like memory and oxidative stress. JM-20 has demonstrated protective effects on short-term memory acquisition and consolidation, along with antioxidant properties and modulation of Acetylcholinesterase activity. This study assesses the potential protective JM-20 against cognitive decline and age-related memory loss. For the study, aged mice exhibiting aging-associated damage were initially selected. Experimental groups were then formed, and the effect of 8 mg/kg of JM-20 was evaluated for 40 days on aging-related behavior, such as spatial memory, novelty recognition memory, ambulatory activity, and anxiety. Subsequently, animals were sacrificed, and the hippocampal region was extracted for redox studies and to assess acetylcholinesterase activity. Results indicated that JM-20 at 8 mg/kg reversed damage to spatial working and reference memory, exhibiting performance comparable to untreated young adult animals. Furthermore, JM-20 preserved the enzymatic activity of superoxide dismutase, catalase, and total sulfhydryl levels in age-related cognitive impairment in mice, indicating a potent protective effect against oxidative events at the brain level. However, only young, healthy animals showed decreased acetylcholinesterase enzyme activity. These findings provide preclinical pharmacological evidence supporting the neuroprotective activity of JM-20, positioning it as a promising therapeutic candidate for treating memory disorders associated with aging.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Cognitive DysfunctionAgingAnimalsMiceMaleAcetylcholinesteraseNeuroprotective AgentsOxidative StressHippocampusSpatial MemoryAntioxidantsMaze Learning

Stichwörter der Autor:innen

Age-related cognitive impairment in miceDementiaJM-20Neuroprotection

Substanzen

AcetylcholinesteraseNeuroprotective AgentsAntioxidants

Autor:innen und Institutionen

  • Laboratorio de Neurofarmacología Experimental, Centro de Investigación y Desarrollo de Medicamentos (CIDEM), Ave 26 No. 1605 Boyeros y Puentes Grandes, La Habana, 10600, Cuba.
  • Departamento de Biología, Facultad de Química y Biología, Universidad de Santiago de Chile, USACH, Santiago, Alameda, 3363, Chile.
  • Facultad de Ciencias Químicas y Farmacéuticas, Advanced Center for Chronic Diseases (ACCDiS), Universidad de Chile, Santos Dumont 964, Casilla 233, Santiago, Chile.
  • Programa de Pós-graduação em Bioquímica Toxicológica, Universidade Federal de Santa Maria (UFSM), Avenida Roraima 1000, Santa Maria, RS, 97105-900, Brazil.
  • Laboratorio de Neurofarmacología Experimental, Centro de Investigación y Desarrollo de Medicamentos (CIDEM), Ave 26 No. 1605 Boyeros y Puentes Grandes, La Habana, 10600, Cuba. luis.fonseca@cidem.cu.
  • Laboratorio de Neurofarmacología Experimental, Centro de Investigación y Desarrollo de Medicamentos (CIDEM), Ave 26 No. 1605 Boyeros y Puentes Grandes, La Habana, 10600, Cuba. yanier.nunez@cidem.cu.

Förderung

  • This work was partially supported by the Innovation Financial Funding (FONCI-Cuba) project.

Zitieren

APA

Wong-Guerra, M., Montano-Peguero, Y., Ramírez-Sánchez, J., Alfonso, E. G., Hernández-Enseñat, D., Isaac, Y. A., Padrón-Yaquis, A. S., da Rocha, J. B. T., Fonseca-Fonseca, L. A., & Núñez-Figueredo, Y. (2025). Effect of JM-20 on Age-Related Cognitive Impairment in Mice. Neurochemical Research. https://doi.org/10.1007/s11064-024-04254-1

Vancouver

Wong-Guerra M, Montano-Peguero Y, Ramírez-Sánchez J, Alfonso EG, Hernández-Enseñat D, Isaac YA, et al. Effect of JM-20 on Age-Related Cognitive Impairment in Mice. Neurochemical Research. 2025. doi:10.1007/s11064-024-04254-1

BibTeX
@article{WongGuerra2025,
  author = {Wong-Guerra, Maylin and Montano-Peguero, Yanay and Ramírez-Sánchez, Jeney and Alfonso, Enrique García and Hernández-Enseñat, Daniela and Isaac, Yeniceis Alcántara and Padrón-Yaquis, Alejandro Saúl and da Rocha, João Batista Teixeira and Fonseca-Fonseca, Luis Arturo and Núñez-Figueredo, Yanier},
  title = {Effect of JM-20 on Age-Related Cognitive Impairment in Mice},
  journal = {Neurochemical Research},
  year = {2025},
  doi = {10.1007/s11064-024-04254-1}
}
Kostenlos starten →